dronabinol

Oral cannabinoids in people living with HIV on effective antiretroviral therapy

ABSTRACT Only one study involving 62 patients examined the effects of cannabinoids on immune function and parameters associated with HIV infection. Participants in this study were assigned to either a 3.95% THC marijuana cigarette, a 2.5 mg dronabinol capsule or a place capsule three times per day for 21 days. For the marijuana group, there …

Oral cannabinoids in people living with HIV on effective antiretroviral therapy Read More »

Scroll to Top
{"cart_token":"","hash":"","cart_data":""}